Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lung Cancer Patients
100%
Superoxide Dismutase Mimetic
100%
Gm4419
100%
Stereotactic Body Radiation Therapy
100%
Galeras
27%
Pulmonary Toxicity
18%
Oral mucositis
18%
Specific Aims
18%
Oropharynx
9%
NSCLC Patients
9%
Locally Advanced
9%
Cancer Patients
9%
Immunohistochemistry
9%
Cancer Treatment
9%
Histology
9%
Growth Factors
9%
Early-stage Lung Cancer
9%
Progression-free Survival
9%
Radioprotectant
9%
Antitumor Effect
9%
Lung Cancer Treatment
9%
Phase II Trial
9%
Therapy-related
9%
Phase I Study
9%
Radiographic Evidence
9%
In Cancer
9%
Patient Demographics
9%
Advanced Squamous Cell Carcinoma
9%
Metastatic Lung Disease
9%
Inflammation
9%
Treatment Outcome
9%
Antitumor Action
9%
Radiation Therapy
9%
Tumor
9%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
9%
Chemotherapeutic Treatment
9%
Radiation Toxicity
9%
Fibrosis
9%
Pulmonary Injury
9%
Predictive Value
9%
Change from Baseline
9%
Pulmonary Function
9%
Oxidative Markers
9%
Lung Cancer
9%
Circulating Cytokines
9%
Computational Imaging
9%
Intensity-modulated Radiation Therapy
9%
Pulmonary Fibrosis
9%
Concurrent Cisplatin
9%
Pneumonitis
9%
Small Molecules
9%
Pharmacology, Toxicology and Pharmaceutical Science
Avasopasem Manganese
100%
Lung Cancer
100%
Superoxide Dismutase
100%
Oral Mucositis
18%
Preclinical Study
18%
Lung Toxicity
18%
Neoplasm
18%
Malignant Neoplasm
18%
Clinical Study
18%
Growth Factor
9%
Cytokine
9%
Cisplatin
9%
Lung Fibrosis
9%
Progression Free Survival
9%
Fibrosis
9%
Squamous Cell Carcinoma
9%
Inflammation
9%
Lung Disease
9%